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ABSTRACT 
Comparative Aspects of Cholesterol Metabolism and Lecithin:Cholesterol 
Acyltransferase Activity in Dogs and Cats.  (December 2007) 
Rebecca Joyce Angell, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. John E. Bauer 
 Little research has focused on the relationship between lecithin:cholesterol 
acyltransferase (LCAT) activity and cholesterol metabolism in dogs and cats.  To study 
weight loss and cholesterol metabolism in dogs, four experimental weight-loss diets 
were fed to 12 obese female beagles for 8 wk in a partial crossover design (n = 6).  High- 
(HGI) or low-glycemic index (LGI) starch and diacylglycerol or triacylglycerol oil were 
combined to compose diets with similar fatty acid (FA) profiles.  Body weight was 
measured weekly.  Fasted blood samples were drawn at wk1, wk4, and wk8 to measure 
plasma total (TC), unesterified (UC), and esterified cholesterol (EC) concentrations, 
LCAT activity, and FA composition of the phospholipid (PL) and EC fractions.  All 
groups lost weight.  UC increased from wk1 to wk4 (p < 0.05).  LCAT activity increased 
from wk1 to wk4 and remained elevated at wk8 (p < 0.05).  Plasma PL FA profiles 
reflected the diets fed with few diet or time effects.  Plasma EC FA profiles reflected the 
specificity of LCAT for linoleic acid (LA) with minimal diet or time effects.  We 
conclude that weight reduction in dogs occurs in conjunction with increased LCAT 
activity and altered plasma cholesterol fractions but not changes in plasma PL or EC FA 
profiles.  To measure the activity and demonstrate the FA specificity of LCAT in felines 
fed varying types of fat, 29 female cats were fed diets enriched with high-oleic 
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sunflower (n = 9), menhaden fish (n = 10), or safflower (n = 10) oil (8g oil/100g kibble) 
for 4 wk.  Fasted blood samples were drawn at d0, d14, and d28 for determination of the 
blood parameters mentioned previously.  LCAT and TC showed no time or diet effects.  
UC decreased at d28 compared to d0 and d14, while EC increased at d28 compared to d0 
and d14 (all p < 0.05).  Plasma EC FA profiles reflected the specificity of LCAT for LA 
with many diet and time effects but contained no docosahexanoic acid (DHA).  We 
conclude that feline LCAT has no measurable affinity for DHA, but both feline and 
canine LCAT demonstrated specificity for LA regardless of diet fed. 
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CHAPTER I 
INTRODUCTION 
Dog Study 
 
 Overweight and obesity are common problems among companion animals, 
affecting an estimated 25 to 40% of dogs and cats seen in private veterinary practice (1).  
Significant health repercussions such as greater risk for earlier morbidity, shortened 
lifespan, insulin resistance, and osteoarthritis are associated with excess body weight in 
dogs (2, 3).  Typically, this is addressed by decreasing calorie intake and increasing 
energy expenditure to promote weight loss (4).  Another approach proposed recently is 
the replacement of the typical form of fat found in the diet, triacylglycerol (TAG), with a 
form of fat normally found in very low quantities in the diet, diacylglycerol (DAG), 
especially 1,3-DAG (5).   
Animal studies report suppression of diet-induced body weight and visceral fat 
gain in rats and obesity-prone mice fed diets greater than 10% by weight 1,3-DAG vs. 
TAG (5).  Such findings have led to human studies, which have demonstrated a decrease 
in visceral fat mass in normal weight, overweight, and obese subjects associated with 
1,3-DAG vs. TAG intake (5).  Because DAG and TAG oils have been observed to have 
similar digestibilities, energy content per gram, and absorption, it has been hypothesized 
that the metabolic differences observed may be due to the structural differences between 
the two lipids (6, 7).   
 
This thesis follows the style of Lipids. 
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During digestion of TAG, the fatty acids at the sn-1 and sn-3 positions are  
 
hydrolyzed, resulting in 2-monoacylglycerols (2-MAG) and free fatty acids.  After 
absorption into the intestinal mucosal cell, these components are re-esterified into TAG, 
packaged into chylomicrons, and eventually enter general circulation.  In contrast, the 
digestion of 1,3-DAG produces free fatty acids and 1(3)-MAG, which exhibit less 
efficient re-esterification into TAG than 2-MAG and free fatty acids in the intestinal 
mucosal cells (6, 8).  As with the TAG oil components, the fatty acids from DAG that 
are re-esterified into TAG are packaged into chylomicrons and eventually enter general 
circulation.  Less clear is the fate of the fatty acids that are not re-esterified in the 
intestinal mucosal cells after digestion of 1,3-DAG and absorption of its components.  
One possibility is that these fatty acids are oxidized within intestinal mucosal cells.  
Indeed, animal studies have demonstrated an increase in small intestinal β-oxidation in 
lean and obese mice fed diets high in DAG (9, 10).   
One effect of obesity often observed in canines is increased plasma cholesterol 
(11).  This phenomenon has also been seen in cats, as well as a reduction in plasma 
cholesterol in conjunction with weight loss (12, 13).  This decrease in plasma cholesterol 
during weight loss could be explained by an increase in the activity of 
lecithin:cholesterol acyltransferase (LCAT) and efficient scavenging of the resultant 
esterified cholesterol as part of reverse cholesterol transport (RCT).   
Lecithin:cholesterol acyltransferase facilitates RCT by creating a concentration 
gradient of unesterified cholesterol between peripheral cells and high density lipoprotein 
(HDL) particles.  After being synthesized in the liver, LCAT is released into general 
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circulation where it is incorporated into HDL particles and, to a much lesser extent, low 
density lipoprotein (LDL) particles (14).  Once bound to HDL, LCAT is located on the 
surface of the particle and can be stabilized in an active conformation by apolipoprotein 
A-I (apoA-I), the principal activating cofactor of LCAT.  As the HDL particle circulates, 
LCAT preferentially catalyzes the transfer of an unsaturated acyl group from the sn-2 
position of phosphatidylcholine (PC) located on the surface of the HDL particle to 
unesterified cholesterol from peripheral tissues, resulting in the formation of 
lysophosphatidylcholine (LPC) and esterified cholesterol (14) (Figure 1).  The newly 
formed EC is transferred into the core of the HDL particle and will eventually be 
released into the liver for processing.  The LPC diffuses into solution and binds to 
albumin for transport back to the liver.  With the conversion of unesterified cholesterol 
into esterified cholesterol, LCAT decreases the concentration of unesterified cholesterol 
in circulation relative to the concentration of unesterified cholesterol in the peripheral 
cells, maintaining the concentration gradient.  In this way, LCAT facilitates reverse 
cholesterol transport (15).   
Current knowledge of canine LCAT activity is limited.  No studies have reported 
the relationship between LCAT activity and weight loss in dogs, and few have reported 
the activity of canine LCAT in general.  One study reported an increase in LCAT 
activity that was associated with an increase in plasma cholesterol concentrations in 
mixed-breed dogs fed a high-fat diet (16).  These data support the concept of a 
relationship between LCAT activity and cholesterol concentrations, which is not 
counterintuitive as enzyme activities are often influenced by the availability of substrate.   
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The main objective of this dietary trial was to determine the efficacy of four 
experimental weight loss diets differing in starch type (high- or low- glycemic index) 
and oil type (DAG or TAG).  Secondary to this and a main focus of this thesis, the 
relationship between weight loss, cholesterol concentrations, and LCAT activity were 
investigated, as well as the effects of dietary DAG vs. TAG on plasma phospholipid and 
esterified cholesterol fatty acid compositions.  We hypothesized that obese dogs would 
exhibit decreased plasma total cholesterol concentrations during weight loss and that if 
this occurred, it would do so in conjunction with an increase in plasma LCAT activity.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Diagram of the reaction catalyzed by lecithin:cholesterol 
acyltransferase (LCAT). 
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Cat Study 
 
 It has been generally accepted that cats lack the Δ6 desaturase enzyme that is 
required for the formation of long-chain polyunsaturated fatty acids (LCPUFAs) from 
the typical essential fatty acid (EFA) precursor for other mammalian species, linoleic 
acid (LA, 18:2n-6).  In species that express Δ6 desaturase, LA is elongated and 
desaturated to form arachidonic acid (AA, 20:4n-6), which is subsequently metabolized 
to form other LCPUFAs and metabolites necessary for normal biological functioning.  
Rivers et al demonstrated in 1975 that cats have extremely low or nonexistent Δ6 
desaturase activity by maintaining cats on diets containing LA as the predominant fatty 
acid without any other long chain fatty acids for an average of 15 months (17).  Despite 
the high levels of LA fed, only very low amounts of AA were detected in plasma 
phospholipids, indicating that despite an abundance of substrate, the Δ6 desaturase 
enzyme was minimally active.  The observation of extremely limited or no Δ6 desaturase 
activity in cats has been confirmed by other researchers and has led to the current view 
that cats require dietary AA due to an inability to synthesize it from precursors (18).   
Contrary to this, more recent studies indicate that cats may have limited, but 
existent, Δ6 desaturase activity.  The presence of small amounts of 20:3Δ5,8,11 observed 
in EFA deficient cats indicates low activity of Δ6 desaturase, since this fatty acid likely 
is a product of elongation and Δ6 desaturation of oleic acid (OA, 18:1n-9) (19).  This 
suggests that cats might have the capacity to synthesize AA from LA; however, due to 
the excessively small amount of 20:3Δ5,8,11 detected, authors maintained that such a low 
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activity of Δ6 desaturase would be metabolically insignificant and that AA would be 
nutritionally essential for cats (19).  More definitive evidence of Δ6 desaturase activity 
in cats has been demonstrated using stable isotope techniques combined with gas 
chromatography and mass spectrometry.  Pawlosky et al found that 48 hours after oral 
administration of deuterium-labeled LA to cats that had been maintained on an EFA-
deficient diet, labeled 18:3n-6 was present in plasma, but only at 0.06% of the amount 
administered (20).  In concert, these studies demonstrate that Δ6 desaturase activity can 
be observed in felines, but only to a small degree.  The primary objective of this dietary 
trial was to determine the ability of cats to convert LA to AA after feeding diets rich in 
LA (from safflower oil), OA (from high-oleic sunflower oil), or LCPUFA (from 
menhaden fish oil). 
 A feline enzyme that has received much less attention than Δ6 desaturase is 
LCAT.  Very little research has focused on the activity of LCAT in cats.  Butterwick et 
al utilized an artificial proteoliposome substrate to determine LCAT activity in cats and 
measure differences between life stages and sexes.  For adolescent (age 32 weeks) cats, 
this study reported an activity of 239 ± 44 nmol of EC formed/ml/h and greater activity 
in intact females than in either intact or castrated males (21).  Slightly more data are 
available describing the fatty acid specificity of feline LCAT as shown by measuring the 
fatty acid profile of plasma EC.  Platinga et al found that docosahexanoic acid (DHA, 
22:6n-3), a LCPUFA present in fish oils, is not incorporated into feline plasma EC even 
when present in significant amounts in the diet (22).  Contrary to this, Liu et al 
demonstrated the presence of DHA in feline plasma EC (diet not reported) (23).  In light 
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of how little is known about feline LCAT, we measured its activity in plasma and 
determined the FA profile of plasma EC as part of the larger study.  We hypothesized 
that dietary fat type would not impact LCAT activity in adolescent cats, but it would 
modulate the fatty acid composition of the plasma EC. 
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CHAPTER II  
MATERIALS AND METHODS 
Dog Study 
 
Experimental Design.  This research project was part of a larger project 
investigating the effects of different types of dietary carbohydrate and oil on weight loss, 
metabolism, and lipid parameters in obese dogs.  The protocol for this study was 
approved by the Texas A&M University Laboratory Animal Use Committee.  The dogs 
were housed at the Laboratory Animal Research and Resources (LARR) facility, cared 
for by its resident veterinarian and staff, and fed by members of the Companion Animal 
Nutrition lab in the College of Veterinary Medicine and Biomedical Sciences.  Twelve 
adult intact female obese beagles were divided into four diet groups of three dogs each.  
After a four week acclimation period to the gruel-based diet form, the groups were then 
fed their respective experimental weight loss diets for 8 weeks.  During a 17-week 
washout period, the dogs were fed a weight-gain diet to attain their initial levels of 
obesity.  Afterward, the acclimation period and experimental diet feedings were repeated 
with each group receiving a different diet than it had received previously.  During the 
experimental feeding period, the dogs were fed the amount of kcal required to maintain 
their starting obese body weight as determined by feeding records during stable obesity.  
Food intake was recorded daily and body weight was measured weekly.  Start dates for 
the dogs were staggered to make the acquisition of samples manageable. 
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The experimental diets differed in the type of starch and type of oil they 
contained.  A high- or low- glycemic index starch (waxy corn (W) or high amylose corn 
(A), respectively) was paired with diacylglycerol (DAG) or triacylglycerol (TAG) oil 
and a protein and vitamin source to compose each diet, designated as waxy-DAG (WD), 
waxy-TAG (WT), amylose-DAG (AD), and amylose-TAG (AT).  The starches and oils 
were provided by Kao Corporation (Tokyo, Japan).  The DAG and TAG oils had similar 
fatty acid profiles, which can be found in Appendix A, Table A-1.  Specifically, the dry 
diet mixture consisted of chicken by-product meal (Tyson Foods, Inc., Oklahoma City, 
OK), starch, and a vitamin and mineral premix (Akey, Lewisburg, OH).  On the day of 
feeding these ingredients were combined with the specified oil and sufficient water to 
form a gruel that was fed to the dogs.  The ingredients and fatty acid profiles of the 
experimental diets can be found in Appendix A, Tables A-2 and A-3.  The amount of 
water added to each diet was adjusted to form a palatable texture, according to the 
differing characteristics of the starches.  Due to the high amylopectin content of the 
waxy corn starch, more water was required to form a palatable diet with this ingredient 
than with the high amylose corn starch.  To acclimate the dogs to a gruel-based diet, a 
dry mixture of chicken by-product meal, 50/50 starch blend (50% waxy corn / 50% high 
amylose corn by weight), and a vitamin and mineral premix was combined with an oil 
mixture (50% canola / 50% vegetable oil by volume) and water and fed to the dogs.  The 
fatty acid profile of the acclimation diet can be found in Appendix A, Table A-4.   
Blood Sample Collection.  Blood was drawn on the first day of the experimental 
diet period (week 1) before the diets were fed and at weeks 4 and 8 during this period.  
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The dogs were fasted overnight and blood was obtained from a jugular catheter.  
Approximately 7 ml of blood were collected into tubes containing EDTA (1.5 mg/ml) as 
an anticoagulant.  Plasma was harvested by low speed centrifugation at 100 × g for 10 
min and stored in aliquots at -20°C for subsequent analysis. 
Plasma Cholesterol Analysis.  Plasma samples were analyzed for total (TC) and 
unesterified cholesterol (UC) concentrations enzymatically using a microplate reader 
(Molecular Devices Corporation, Menlo Park, CA) and its software (SoftMax® Pro, 
Molecular Devices Corporation, Sunnyvale, CA).  This data was then used to calculate 
esterified cholesterol (EC) concentrations.  Six (6) µl of plasma and 200 µl of reagent 
(described below) were applied in triplicate to microplate wells and mixed by the 
microplate reader.  The plate was incubated at 37°C for 30 min, allowed to sit at room 
temperature for another 30 min, and the absorbance was read at 490 nm.  A standard 
curve was generated by replacing sample plasma in the above procedure with 6 µl of 
calibrator standards (100, 200, and 400 mg/dl) (Sigma Diagnostics, St. Louis, MO), also 
in triplicate.  Distilled water served as a blank.  TC and UC concentrations were 
calculated by the microplate software based on the slope of the standard curve and 
expressed as mmol/l.  EC concentrations were calculated as the difference between TC 
and UC.  
Cholesterol Reagents.  The enzymatic cholesterol reagents were prepared 
according to the procedure described by Warnick (24).  One (1) L of 50 mM PIPES 
buffer (pH 6.9) was prepared using 17.3 g of disodium salt (Sigma-Aldrich, St. Louis, 
MO) to form the buffer and 1.292 g of sodium cholate and 1 ml of Triton X-100 (Sigma-
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Aldrich, St. Louis, MO) to extend the shelf life.  Reagent A was formed by mixing 0.102 
g of 4-aminoantipyrine and 1.492 g of KCl (Sigma-Aldrich, St. Louis, MO) with 100 ml 
of the PIPES buffer.  Reagent B was formed by dissolving 0.08 g of 2-hydroxy-3,5-
dichlorobenzenesulfonic acid, sodium salt (Research Organics, Inc., Cleveland, OH) in 
100 ml of the PIPES buffer.  Reagents A and B were mixed in equal parts along with the 
enzymes cholesterol esterase (0.5 U/ml), cholesterol oxidase (0.5 U/ml), and horseradish 
peroxidase (10 U/ml) (Sigma-Aldrich, St. Louis, MO) to form reagent C.  The procedure 
was repeated with the omission of cholesterol esterase to form reagent C′.   
TC was measured using reagent C.  When added to the sample plasma, reagent C 
catalyzed the following series of reactions:  the hydrolysis of EC to UC and fatty acids 
by cholesterol esterase; the oxidation of UC into cholest-4-en-3-one and H2O2 by 
cholesterol oxidase; and the synthesis of quinoneimine dye from 4-aminoantipyrine, 2-
hydroxy-3,5-dichlorobenzensulfonic acid, and H2O2 by horseradish peroxidase.  
Quinoneimine dye has a red color that can be measured at 490 nm.  In this way, reagent 
C allows the quantitation of EC+UC in plasma.  UC was measured using reagent C′.  
Because this reagent lacks cholesterol esterase, it only allows the detection of 
endogenous UC. 
LCAT Activity Assay.  Plasma samples were assayed for LCAT activity 
according to the procedure described by Gillett & Owens (25).  This technique utilizes 
endogenous substrate with which radiolabeled tracer is equilibrated.  Results are based 
on the percent of tracer esterified as an index of endogenous UC esterified.  As a control, 
plasma from week 1 was pooled, mixed, and stored in aliquots at -20°C.  Each time the 
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LCAT assay was performed, a control sample was treated as a plasma sample except that 
it was not run in duplicate.  Once LCAT activities had been determined for all samples 
and controls, a median control value was determined and used to normalize the data. 
14C Substrate Preparation.  A 5% (w/v) bovine serum albumin (BSA) (SeraCare 
Diagnostics, Milford, MA) solution in 0.2 M NaH2PO4 buffer (pH 7.4) (Sigma-Aldrich, 
St. Louis, MO) was prepared and incubated at 56°C for 30 min to destroy any 
endogenous LCAT activity.  It was transferred to a clean vial and weighed.  For each 1 g 
of BSA solution, 2 µCi of 14C-unesterified cholesterol (UC) (PerkinElmer, Boston, MA) 
solution was prepared.  This was done by placing the calculated amount of UC solution 
into a clean vial and evaporating it to dryness under N2.  The UC was then resuspended 
in 100 µl of acetone and added dropwise to the BSA solution and mixed using a vortex 
mixer to bind the UC to the BSA.  The acetone was evaporated from the UC/BSA 
emulsion under N2 for 30 min with mixing every 10 min.  The emulsion was weighed 
and dH2O was added until the original weight of the BSA solution was achieved to 
replace any water lost due to evaporation.    
 Sample Preparation.  Plasma samples were allowed to thaw at 6°C for 
approximately 15 min.  Each sample was prepared in duplicate with a blank.  In each 
tube, 200 µl of sample and 40 µl of DTNB solution (1.4 mM dithionitrobenzoic acid in 
0.2 M NaH2PO4 buffer, pH 7.4) (Sigma-Aldrich, St. Louis, MO) were pre-incubated in a 
37°C water bath for 30 min to reversibly inhibit LCAT activity.  Then 60 µl of the 
UC/BSA emulsion was added and the mixture was mixed using a vortex mixer and 
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incubated in a 37°C water bath for 4 hr to equilibrate the 14C-UC with endogenous 
plasma UC.   
Enzyme Assay.  Forty (40) µl of mercaptoethanol solution (0.1 M 
mercaptoethanol in 0.2 M NaH2PO4 buffer, pH 7.4) (Sigma-Aldrich, St. Louis, MO) was 
added to each sample and duplicate in 20-second intervals to reverse the inhibition of 
LCAT by DTNB and activate the reaction.  Forty (40) µl of saline (0.9% NaCl) was 
added to each blank to act as a negative control.  After another 30-min incubation at 
37°C, 4 ml of chloroform:methanol (2:1, v/v) with 0.2% acetic acid was added in 20-
second intervals in the same order as the mercaptoethanol and saline solutions to stop the 
reaction and extract total lipids.  The samples were stored under N2 at -20°C overnight.   
 Lipid Extraction and Separation.  After adding 2 ml of dH2O and shaking for 5 
min, the samples were centrifuged at 1400 × g for 20 min.  The lower chloroform phase 
was transferred to clean test tubes and evaporated to dryness under N2.  Fifty (50) µl of 
chloroform was added to each tube to resuspend the lipids applied in narrow streaks to 
20 × 20 silica gel G TLC plates (Analtech, Newark, DE) that had been washed by 
developing in chloroform:methanol (2:1, v/v) with 0.2% acetic acid and dried in a 
glassware dryer overnight. Three (3) samples plus 20 µl of a TLC standard (#18-5A, Nu-
Check Prep, Inc., Elysian, MN) to aid in visualizing the lipid subfractions were applied 
per plate.  The plates were developed in hexane:ether:glacial acetic acid (80:20:1, v/v/v) 
until the solvent front reached 1 cm from the top of the plate to separate the lipid 
subfractions.  After the plates were dry, the lipid subfractions were visualized in an I2 
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chamber and the UC and EC fractions were marked and scraped into labeled scintillation 
vials with 5 ml of liquid scintillation fluid (UltimaGold, PerkinElmer, Boston, MA).   
Liquid Scintillation Counting.  A Packard 1900 TR Liquid Scintillation Analyzer 
(Packard Instruments Co., Downers Grove, IL) was used to count the radioactivity in the 
UC and EC fractions. The ratio of radioactivity in the EC fraction to the radioactivity in 
the TC of the samples minus the ratio of radioactivity in the EC fraction to the 
radioactivity in the TC of the blanks was used as a measure of the percent esterification 
of endogenous UC by LCAT.  Results were transformed from percent UC esterified to 
nmol UC esterified per ml of plasma per hour using the concentration of UC in that 
plasma sample as determined by the plasma cholesterol assay.  See Appendix B for the 
equations used to calculate LCAT activity. 
 Lipid Extraction.  Five hundred (500) µl of plasma was combined with 9 ml of 
chloroform:methanol (2:1, v/v) with 0.2% acetic acid and shaken for 20 min.  Two (2) 
ml of dH2O were added and the samples were shaken for an additional 10 min.  After 
centrifugation at 1400 × g for 10 min to separate the lipid fraction, the bottom layer was 
transferred to a clean test tube and 5 ml of chloroform:methanol:water (3:48:47, v/v/v) 
was added with subsequent shaking for 10 min as a wash.  The samples were centrifuged 
again at 1400 × g for 10 min and the bottom layer was transferred to a clean teflon-lined 
screw capped test tube and stored under N2 at -20°C overnight. 
Thin Layer Chromatography.  Extracted plasma samples were evaporated to 
dryness under N2 and 100 µl of CHCl3 was added to each tube.  Fifty (50) µl of each 
sample was applied in narrow streaks to 20 × 20 silica gel G TLC plates (Analtech, 
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Newark, DE) which had been washed in chloroform:methanol (2:1, v/v) with 0.2% 
acetic acid and dried in a glassware dryer overnight.  Three (3) samples plus a TLC 
standard (#18-5A, Nu-Check Prep, Inc., Elysian, MN) to aid in visualizing the lipid 
subfractions were applied to each TLC plate, which was developed in 
hexane:ether:glacial acetic acid (80:20:1) until the solvent front reached 1 cm from the 
top of the plate to separate the lipid subfractions.  The plates were allowed to dry, then 
the phospholipid fraction was scraped into a clean test tube.  The plates were then 
visualized in I2 and the EC fraction was marked and scraped into a clean test tube.   
Methylation.  After the addition of 2 ml of 4% H2SO4 in methanol to each 
sample, they were mixed and incubated for 1 hr in a water bath at 90°C to catalyze the 
formation of methyl ester derivatives of the fatty acids that were incorporated into the 
phospholipids and esterified cholesterol.  After standing at room temperature for 5 min 
and the addition of 3 ml of hexane to each sample, they were mixed, centrifuged at 1400 
× g for 15 min, and the top layer was transferred to a clean test tube to isolate the fatty 
acid methyl esters (FAMEs).  The samples were stored under N2 at -20°C overnight until 
the time of further analysis. 
Gas Chromatography.  The FAMEs samples were concentrated by evaporating 
them to dryness under N2 and adding back 40 µl of hexane, 20 µl of which was loaded 
into a gas chromatography (GC) vial insert and placed on a Hewlett Packard 6890 Series 
Injector.  Three (3) µl of each sample were injected onto a FAMEWAX™ fused silica 
capillary column (30 m long, 0.25 µm thickness, and 0.32 mmID) (Restek, Bellefonte, 
PA) in a Hewlett Packard 5890 Series II Gas Chromatograph (Hewlett Packard Co., Palo 
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Alto, CA) with a flame ionization detector.  Helium was used as the carrier gas at an 
initial velocity of 28.3 cm/sec and flow of 1.25 ml/min.  Initial oven temperature was 
held at 160°C for 10 min, then increased at a rate of 1.0°C/min until a final temperature 
of 220°C was reached.  Results were generated with Hewlett Packard ChemStation 
software package.  Authentic FAMEs standards (#68-A, plus 17:0, 18:1n7, 20:5n3, and 
22:4n6, Nu-Check Prep, Inc., Elysian, MN) were used to identify individual fatty acid 
peaks based on retention times. 
Data Analysis.  Statistical analyses were performed using Statistix8 (Analytical 
Software, Tallahassee, FL) for Windows.  The Shapiro-Wilks test was used to determine 
normal distribution of data.  Non-normally distributed data were either transformed 
using log, square root, or inverse to achieve normal distribution or analyzed with the 
Kruskal-Wallis one-way ANOVA.  Repeated measures ANOVA was used to test LCAT 
and cholesterol data for time effects, main effects of starch and oil type, and for 
interactions.  One-way ANOVA was used to test plasma EC FA profile and FA type 
distribution data for diet effects at each time point and time effects within each diet.  For 
all data, a p-value < 0.05 was considered significant and multiple comparisons were 
performed where appropriate. 
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Cat Study 
 
 Experimental Design.  This research project was part of a larger project to 
investigate the ability of cats to convert linoleic acid to arachidonic acid.  The protocol 
for this study was approved by the Texas A&M University Laboratory Animal Use 
Committee.  The cats were housed at the Laboratory Animal Research and Resources 
(LARR) facility, cared for by its resident veterinarian and staff, and fed by members of 
the Companion Animal Nutrition lab in the College of Veterinary Medicine and 
Biomedical Sciences.  Twenty-nine adolescent (ages 7 to 9 months) intact female cats 
were randomly divided into three diet groups, two consisting of 10 cats each and one 
consisting of 9 cats.  Cats were individually housed during the experimental period and 
daily food consumption was monitored.  Body weight was measured weekly as an 
indication of adequate intake.  The cats were fed the calculated amount of kcal to 
maintain healthy growth according to the following equation: Metabolizable Energy 
(kcal) = 134 × [body weight (kg)]0.67.  Cats were assumed to be 80% grown at the 
beginning of the study (26).  Start dates for the cats were staggered to make the 
acquisition of samples manageable. 
A commercially available, low-fat adult cat diet (Kit ‘N Kaboodle®, Nestle 
Purina, St. Louis, MO) was top-dressed with one of three oils (8 g oil/100 g kibble) to 
compose each diet, which was fed for 4 wk.  High-oleic sunflower (H) (Clear Valley®, 
Cargill, Minneapolis, MN), menhaden fish (M) (Virginia Prime Gold®, Omega Protein, 
Houston, TX), and safflower (S) (Oilseeds International, San Francisco, CA) oils were 
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used to provide oleic acid, eicosapentanoic acid (EPA, 20:5n-3)/DHA, or LA, 
respectively. The fatty acid profiles of the pre-experimental diet (Hill’s Science Diet® 
Kitten Original), Kit ‘N Kaboodle®, each oil, and each diet can be found in appendix C, 
Tables C-1 and C-2.  The same lot of each diet constituent was used throughout the 
experimental period.   
Blood Sample Collection.  Fasted blood samples (7 ml) were taken on d 0, 14 
and 28.  Food was withheld overnight prior to the samples being taken, which were 
obtained via saphenous vein into an evacuated tube containing EDTA (1.5 mg/ml) as an 
anticoagulant.  Plasma was harvested by centrifugation at 100 × g for 10 min and stored 
in aliquots at -20°C for subsequent analysis. 
Plasma Analyses. Plasma cholesterol analysis, LCAT activity assay, lipid 
extraction, thin layer chromatography, methylation, and gas chromatography were 
performed as described previously. 
Data Analysis.  Statistix8 (Analytical Software, Tallahassee, FL) for Windows 
was used to perform the Shapiro-Wilks test for normal distribution on all data.  Non-
normally distributed data were either transformed using log, square root, or inverse to 
achieve normal distribution or analyzed with the Kruskal-Wallis one-way ANOVA.  
Using SAS, repeated measures ANOVA was performed on transformed LCAT and 
cholesterol data using PROC MIXED to test for main effects of time and diet and for 
interactions.  Statistix8 was used to perform one-way ANOVA testing on plasma EC FA 
profile and FA type distribution data for diet effects at each time point and time effects 
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within each diet.  For all data, a p-value < 0.05 was considered significant and multiple 
comparisons were performed where appropriate.  
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CHAPTER III 
RESULTS 
Dog Study 
 
Animals and Diets.  Daily monitoring of diet consumption revealed that the 
dogs consumed an average of only 68 ± 4(SEM)% of the diets offered overall per day on 
a weight basis.  Considering that the dogs were fed the estimated amount of kcal 
necessary to maintain their starting obese body weights, it is not surprising that this 
voluntary restriction resulted in all dogs losing weight independent of diet.  A starch 
effect was seen, however, on the average percent of starting obese body weight lost per 
week.  Dogs on the high amylose corn (LGI) diets lost an average of 2% body weight 
per week whereas dogs on the waxy corn (HGI) diets lost an average of 1% body weight 
per week.  This coincides with lower total digestibilities of the high amylose corn diets 
(AD 79.8 ± 5.0% and AT 82.1 ± 4.3%, mean ± SEM) vs. the waxy corn diets (WD 95.0 
± 3.0% and WT 93.7 ± 4.5%, mean ± SEM).  Thus, even though all dogs were 
consuming a similar amount of their respective diet on a weight basis, the metabolizable 
energy derived from the diets varied due to starch type.   
Plasma Cholesterol.  Inspection of the EC data revealed that values for some 
dogs were negative.  Because this value was calculated using the measured values for 
TC and UC, a negative value for EC indicates an error in the measurement of either TC, 
UC, or both.  In these instances, the TC, UC, and EC data for that dog at that time period 
were eliminated from further analysis and SAS PROC MIXED was used to perform 
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repeated measures analysis on the resulting unbalanced data set.  In all, 6 sets of 
cholesterol data were disregarded as follows: from wk 1, 1 dog each from diet groups 
WD and WT; from wk 4, 1 dog each from diet groups AD and WT and 2 dogs from diet 
group AT.  Statistical analysis of the abbreviated data set revealed an overall starch 
effect for both TC and EC concentrations with values for waxy corn groups higher than 
those for high amylose groups in both cases (Appendix A, Figure A-1).  An overall time 
effect was seen on UC concentrations, which were elevated at wk 4 compared to wk 1 
although both measurements were similar to values at wk 8 (Appendix A, Figure A-1). 
LCAT Activity.  Repeated measures analysis revealed a main time effect but no 
diet effect or diet × time interaction for LCAT activity (Figure 2).  LCAT activity 
increased from wk 1 to wk 4 and remained elevated at wk 8. 
Plasma Esterified Cholesterol Fatty Acid Composition.  Few differences were 
observed between starch groups, oil groups, and diet (starch × oil) groups in the plasma 
EC fatty acid profiles (Table 1).  An overall oil effect was seen for 20:1n-9, but multiple 
comparisons did not show group differences.  At wk 4, 18:3n-3 concentrations were 
greater in TAG groups than DAG groups.  At wk 8, 14:1n-5 concentrations were greater 
in DAG groups than TAG groups.  Interestingly, there was an overall starch effect for 
16:1n-7 with concentrations being greater in high amylose groups than waxy corn 
groups.  There was also a starch effect at wk 4 for 20:5n-3, although multiple 
comparisons did not reveal any significant differences.  Diet effects were seen at wk 4 
for 20:1n-9 and wk 8 for 16:1n-7, 18:1n-7, and 20:3n-6, but multiple comparisons 
indicated no significant differences.  Similarly, time effects were not widely seen.  A  
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Figure 2 LCAT activities of dogs fed diets differing in starch type (high amylose 
[A] or waxy corn [W]) and oil type (diacylglycerol [D] or triacylglycerol [T])        
(n = 6/group).  Values are mean ± SEM.  Letters not in common indicate a 
significant difference between weeks by repeated measures ANOVA, p < 0.05. 
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Table 1 Dog study plasma esterified cholesterol fatty acid composition (relative %) 
FA  AD AT WD WT 
 Week 1 Week 4 Week 8 Week 1 Week 4 Week 8 Week 1 Week 4 Week 8 Week 1 Week 4 Week 8 
14:0 0.2±0.0 0.2±0.0 0.2±0.0  0.2±0.0 0.2±0.0 0.1±0.0  0.2±0.0 0.2±0.0 0.1±0.0  0.2±0.1 0.2±0.0 0.2±0.0 
14:1n-5 TR 0.2±0.1 0.1±0.0  TR 0.1±0.1 TR  TR 0.1±0.1 TR  TR 0.1±0.0 ND 
16:0 8.0±1.1 9.6±0.8 8.1±0.1  9.0±1.3 8.4±0.4 6.7±1.0  7.7±1.2 8.3±1.4 6.6±0.7  8.5±1.6 7.8±0.7 7.3±1.0 
16:1n-7 1.0±0.1 1.4±0.2 1.2±0.1  1.2±0.2 1.2±0.1 0.8±0.1  1.2±0.3 1.1±0.2 0.8±0.1  1.2±0.3 1.0±0.1 1.0±0.1 
17:0 0.2±0.0 0.1±0.0 0.1±0.0  0.1±0.0 TR TR  0.1±0.0 0.2±0.1 0.2±0.1  0.4±0.2a 0.3±0.2ab        TRb 
18:0 5.1±1.4 3.1±0.9 2.7±0.8  4.8±0.7 3.1±0.7 3.1±1.2  3.2±0.9 3.7±1.5 2.4±0.6  5.1±0.9 4.7±2.1 2.4±0.9 
18:1n-7 4.1±0.3 4.3±0.5 3.8±0.1  4.1±0.5 3.9±0.4 3.0±0.2  3.8±0.4 3.8±0.4 3.3±0.2  3.9±0.5 3.4±0.1 3.6±0.3 
18:1n-9 11.1±0.9 11.3±1.3 11.3±0.2  12.4±1.5 11.4±0.5 9.7±0.6  10.7±1.4 10.3±1.0 10.1±0.3  11.5±1.5 9.9±0.4 10.0±0.4 
18:2n-6 47.1±2.1 50.5±3.1 53.8±1.3  47.8±1.7 52.4±2.0 50.0±3.2  46.6±2.7 49.0±3.1 50.7±2.3  44.8±3.5 48.2±3.2 52.4±2.1 
18:3n-3 0.2±0.0 0.1±0.0 0.2±0.0  0.3±0.0 0.2±0.0 0.2±0.0  0.2±0.0 0.1±0.0 0.2±0.0  0.2±0.0 0.2±0.0 0.2±0.1 
20:0 0.1±0.1 0.2±0.1 TR  0.2±0.1 0.3±0.2 0.1±0.1  0.3±0.2 TR TR  0.2±0.2 TR 0.3±0.3 
20:1n-9 ND TR TR  ND ND ND  TR ND ND  ND ND TR 
20:2n-6 ND ND ND  ND TR ND  ND TR ND  ND TR TR 
20:3n-3 ND ND TR  ND ND ND  TR ND ND  ND ND TR 
20:3n-6 0.4±0.1a 0.2±0.0b 0.2±0.1b  0.4±0.1 0.3±0.0 0.3±0.0  0.3±0.1 0.2±0.0 0.4±0.1  0.3±0.1 0.3±0.1 0.2±0.1 
20:4n-6 13.4±1.7 9.6±1.2 12.1±1.0  11.8±1.7 11.2±0.5 11.8±0.5  14.2±2.0 11.4±0.7 14.6±1.4  13.2±2.3 13.1±1.3 13.5±1.3 
20:5n-3 TR ND ND  TR TR TR  TR TR TR  0.1±0.0 TR TR 
22:0 0.1±0.1 0.1±0.1 0.1±0.1  0.1±0.1 ND 0.2±0.2  TR TR TR  0.4±0.2 TR TR 
22:1n-9 ND ND ND  ND ND ND  ND ND ND  ND ND TR 
22:4n-6 0.1±0.1 TR TR  0.1±0.0 TR TR  TR TR TR  TR 0.1±0.1 1.4±1.3 
22:5n-3 0.3±0.1 0.2±0.1 0.1±0.1  0.3±0.1 0.1±0.1 0.1±0.1  0.2±0.1 0.1±0.1 0.1±0.1  0.3±0.1 0.3±0.1 0.1±0.1 
22:6n-3 ND ND ND  TR ND ND  TR TR ND  TR ND TR 
24:0 ND ND ND  TR ND ND  TR TR ND  TR ND TR 
24:1 7.1±1.2 7.8±2.5 5.3±1.4  6.3±1.3 6.0±1.4 12.5±4.8  8.1±1.9 9.5±2.9 9.9±3.8  6.8±2.2 7.7±1.8 6.1±1.7 
UI 1.3±0.9 1.2±0.7 0.7±0.3  0.6±0.2 1.1±0.3 1.0±0.4  2.3±1.2 1.5±0.5 0.3±0.1  2.6±1.4 2.6±2.4 0.8±0.5 
 
Values given are mean ± SEM; all diet groups n = 6. 
FA = fatty acid; AD = high amylose/DAG; AT = high amylose/TAG; WD = waxy corn/DAG; WT = waxy corn/TAG; ND = not detected;  
TR = trace (< 0.1%); UI = unidentified. 
Superscript letters not in common in a row within a diet group indicate a significant difference between weeks by ANOVA, p < 0.05.
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main time effect for 14:1n-5 showed that concentrations increased from wk 1 to wk 4, 
although wk 8 was similar to both previous weeks.  Main time effects for 17:0, 18:0, and 
22:5n-3 revealed that their concentrations all increased from wk 1 to wk 8, with 
concentrations at wk 4 similar to both wk 1 and wk 8.  Fatty acids 20:5n-3 and 22:0 both 
showed a time effect that was not elucidated by multiple comparisons.  Diet group AD 
exhibited time differences for 20:3n-6 concentrations, with a decrease from wk 1 to wk 4 
that remained at wk 8.  A time effect was seen within the DAG group for 18:3n-3 
concentrations, which decreased from wk 1 to wk 4 and returned to baseline levels at wk 
8.  A time effect was also seen for this fatty acid in the high amylose group, with 
concentrations increasing from wk 1 to wk 4 and decreasing toward baseline so that 
concentrations at wk 8 were similar to both previous measurements.  Arachidonic acid 
(20:4n-6) changed over time in the DAG groups, but multiple comparisons revealed no 
significant differences.   
Plasma Phospholipid Fatty Acid Composition.  As with the plasma EC fatty 
acid composition, few main effects of starch or oil or starch × oil interactions were seen 
in the plasma PL fatty acid profiles (Table 2).  A main oil effect was seen at wk 1 for 
18:3n-3, with higher concentrations in the TAG group than in the DAG group.  At wk 8, 
18:1n-7 concentrations were higher in the DAG group than in the TAG group.  A main 
starch effect was observed at wk 4 for 16:0, with concentrations higher in the high 
amylose group than in the waxy corn group.  At wk 8, 18:0 and 20:4n-6 concentrations 
were both higher in the waxy corn group than in the high amylose group.  Also at wk 8, 
18:1n-9 concentrations were higher in the high amylose group than in the waxy corn  
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Table 2 Dog study plasma phospholipid fatty acid composition (relative %) 
FA  AD AT WD WT 
 Week 1 Week 4 Week 8 Week 1 Week 4 Week 8 Week 1 Week 4 Week 8 Week 1 Week 4 Week 8 
14:0  TRa 0.1±0.0b        TRab  TR TR TR         TRab 0.1 ±0.0a        TRb  TR TR TR 
14:1n-5 ND ND ND  ND ND ND  ND ND ND  ND ND 0.0±0.0 
16:0 9.8±0.8 12.3±0.7 9.7±0.6  9.9±0.9 10.9±0.5 10.3±1.0  9.9±1.1 10.5 ±0.9 7.4±1.5  8.7±0.8 9.4±0.7 8.6±0.6 
16:1n-7 0.5±0.0 0.6±0.1 0.5±0.1  0.4±0.0 0.5±0.0 0.4±0.0  0.4±0.1ab 0.5 ±0.1a 0.3±0.0b  0.4±0.1 0.5±0.1 0.4±0.1 
17:0 0.5±0.0 0.4±0.1 0.4±0.0  0.4±0.0 0.4±0.1 0.4±0.0  0.4±0.1 0.3 ±0.1 0.3±0.1  0.4±0.0 0.4±0.1 0.4±0.0 
18:0 33.5±1.2 35.0±2.8 30.6±0.3  30.7±1.3 31.9±1.5 29.9±0.8  32.4±0.9 34.2 ±1.2 30.9±0.4  31.5±0.4 32.4±0.9 32.1±0.8 
18:1n-7 3.9±0.3 4.0±0.2 3.9±0.2  3.5±0.2 3.5±0.1 3.3±0.1  3.7±0.2 3.8 ±0.1 3.3±0.1  3.2±0.1 3.7±0.3 3.2±0.2 
18:1n-9 5.6±0.4 5.9±0.6 7.0±0.3  6.4±0.4 6.2±0.7 6.7±0.5  5.6±0.3 5.7 ±0.3 5.9±0.4  5.8±0.3 7.5±1.2 5.9±0.3 
18:2n-6 15.8±1.4 15.9±1.9 17.1±0.9  18.3±0.9 17.6±1.6 18.6±0.8  16.3±0.7 15.6 ±0.9 16.5±1.2  16.1±0.4 15.8±0.6 15.7±0.4 
18:3n-3 0.2±0.0 0.1±0.0 0.2±0.0  0.2±0.0 0.2±0.0 0.2±0.0  0.2±0.0 0.1 ±0.0 0.2±0.0  0.2±0.0 0.2±0.0 0.2±0.0 
20:0 0.4±0.1 0.4±0.1 0.4±0.0  0.3±0.0 0.3±0.0 0.3±0.1  0.4±0.1 0.3 ±0.1 0.3±0.1  0.3±0.0 0.4±0.1 0.4±0.1 
20:1n-9 0.2±0.0ab 0.2±0.0a 0.3±0.0b  0.2±0.0 0.2±0.0 0.2±0.0  0.2±0.0 0.1 ±0.0 0.2±0.0  0.2±0.0 0.2±0.0 0.2±0.0 
20:2n-6 0.4±0.0a 0.2±0.0b 0.4±0.0a  0.4±0.1 0.3±0.0 0.3±0.0  0.3±0.0 0.3 ±0.0 0.4±0.1  0.4±0.0 0.3±0.0 0.4±0.0 
20:3n-3 TR ND TR  ND ND ND  TR ND ND  TR TR TR 
20:3n-6 0.8±0.1 0.8±0.2 0.9±0.1  1.1±0.2 1.0±0.1 1.1±0.2  0.9±0.1 1.0 ±0.1 1.1±0.1  1.0±0.1 0.9±0.1 1.0±0.1 
20:4n-6 21.1±1.5 18.2±2.1 21.4±1.1  21.0±1.2 21.1±1.2 21.0±0.9  22.1±2.2 21.3 ±1.6 24.7±1.6  23.4±1.1 21.9±1.8 22.9±0.8 
20:5n-3 0.2±0.0 0.1±0.0 0.2±0.0  0.2±0.0 0.2±0.0 0.2±0.0  0.2±0.0 0.2 ±0.0 0.2±0.0  0.2±0.0 0.2±0.0 0.2±0.0 
22:0 0.6±0.0 0.5±0.1 0.6±0.1  0.5±0.1 0.4±0.1 0.5±0.1  0.5±0.1 0.3 ±0.1 0.6±0.1  0.5±0.0 0.5±0.1 0.6±0.1 
22:1n-9 TR TR TR  TR TR TR  TR TR TR  TR TR TR 
22:4n-6 0.9±0.1 0.7±0.1 1.0±0.1  1.0±0.2 1.0±0.1 1.0±0.2  0.9±0.2 0.8 ±0.1 1.2±0.2  1.1±0.1 1.0±0.1 1.2±0.2 
22:5n-3 2.6±0.4a 1.5±0.2b 2.3±0.2ab  2.3±0.4 1.9±0.1 2.2±0.4  2.5±0.5 2.2 ±0.1 3.1±0.5  3.0±0.2 2.3±0.2 3.0±0.3 
22:6n-3 0.6±0.1 0.6±0.2 0.6±0.1  0.6±0.1 0.4±0.0 0.6±0.1  0.6±0.1 0.4 ±0.1 0.6±0.1  0.5±0.1 0.5±0.1 0.6±0.1 
24:0 0.3±0.0 0.2±0.0 0.4±0.1  0.3±0.0 0.3±0.0 0.3±0.0  0.3±0.0 0.3 ±0.0 0.4±0.1  0.5±0.1 0.3±0.0 0.4±0.1 
24:1 1.4±0.1 1.3±0.1 1.5±0.3  1.6±0.3 1.3±0.1 1.7±0.3  1.3±0.2 1.2 ±0.2 1.7±0.2  1.6±0.1 1.3±0.1 1.8±0.3 
UI 0.6±0.1 0.7±0.3 0.7±0.3  0.6±0.1 0.5±0.2 0.7±0.3  0.7±0.2 0.7 ±0.3 0.6±0.3  0.8±0.1 0.4±0.0 0.6±0.2 
 
Values given are mean ± SEM; all diet groups n = 6. 
FA = fatty acid; AD = high amylose/DAG; AT = high amylose/TAG; WD = waxy corn/DAG; WT = waxy corn/TAG; ND = not detected;  
TR = trace (< 0.1%); UI = unidentified. 
Superscript letters not in common in a row within a diet group indicate a significant difference between weeks by ANOVA, p < 0.05. 
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group.  Overall diet effects were seen for 22:5n-3 and 24:0.  Relative concentrations of 
22:5n-3 were higher in diet group WT than diet group AT, but both were similar to diet 
groups AD and WD.  Diet group WT had higher concentrations of 24:0 than diet groups 
AD and AT, but diet group WD was similar to all diet groups.  At wk 8, a diet effect was 
observed for 22:1 but multiple comparisons did not show significant differences.  As 
with oil, starch, and diet effects, time effects were sparse.  Relative concentrations of 
14:0, 18:0, and 22:5n-3 (docosapentanoic acid, DPA) demonstrated overall time effects.  
At wk 4, 14:0 concentrations were elevated relative to wks 1 and 8.  Concentrations of 
18:0 were higher at wk 4 than at wk 8, but measurements at wk 1 were similar to both 
subsequent measurements.  Docosapentanoic acid concentrations decreased from wk 1 to 
wk 4, then returned to baseline at wk 8. 
Plasma Esterified Cholesterol Fatty Acid Type Distribution.  Fatty acids were 
grouped by degree of saturation (saturated [SFA], monounsaturated [MUFA], or 
polyunsaturated [PUFA]) and by type of unsaturated FA (n-3 or n-6) and the relative 
percentages detected in the plasma EC fraction were summed and averaged (Table 3).  
One-way ANOVA revealed an overall time effect for SFA, PUFA, n-3, and n-6 groups.  
Multiple comparisons showed that SFA decreased from wk 1 to wk 8, with wk 4 values 
similar to both, and no significant differences between weeks for PUFA.  Week 1 n-3 FA 
relative percentages were higher than weeks 4 and 8, while n-6 FA decreased from wk 1 
to wk 8 with wk 4 similar to both.  No diet effects or diet×time interactions were 
observed. 
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Table 3 Dog study plasma phospholipid and esterified cholesterol fatty acid type distributions (relative %) 
FA 
Type  AD AT WD WT 
  Week 1 Week 4 Week 8  Week 1 Week 4 Week 8  Week 1 Week 4 Week 8  Week 1 Week 4 Week 8 
PL                                
SFA  45.2 ± 1.0ab 49.0± 3.3a 42.1±0.6b  42.3±1.9 44.3±1.6 41.8±1.2  44.1±2.0 46.0± 1.6 40.0±1.8  42.0±0.6 43.4±1.3 42.6±1.1 
MUFA  11.6 ± 0.4 11.9± 0.8 13.1±0.2  12.1±0.3 11.7±0.8 12.2±0.6  11.2±0.5 11.4± 0.6 11.4±0.5  11.3±0.3 13.2±1.2 11.7±0.6 
PUFA  42.6 ± 1.0 38.4± 3.8 44.1±0.5  45.1±1.8 43.6±1.2 45.3±1.0  44.1±2.4 41.9± 2.1 48.0±1.7  45.9±0.8 43.0±2.3 45.2±0.8 
n-3  3.7 ± 0.5 2.4± 0.2 3.2±0.4  3.3±0.6 2.6±0.2 3.2±0.6  3.5±0.5 2.9± 0.1 4.1±0.6  4.0±0.2 3.1±0.3 4.1±0.4 
n-6  39.0 ± 1.1 36.0± 3.8 40.9±0.4  41.8±1.4 40.9±1.2 42.1±0.6  40.6±2.2 39.0± 2.1 43.9±1.7  41.9±0.7 39.8±2.1 41.1±0.5 
                                
EC                                
SFA  13.7 ± 2.3 13.2± 1.7 11.2±0.9  14.5±1.1 12.0±0.9 10.3±1.9  11.6±1.7 12.6± 2.9 9.3±1.3  14.8±1.8 13.0±2.7 10.4±1.7 
MUFA  23.4 ± 1.0 25.0± 2.6 21.6±1.4  24.1±1.7 22.6±1.4 26.1±4.0  23.9±1.0 24.9± 2.6 24.2±3.4  23.4±3.5 22.1±1.9 20.8±1.2 
PUFA  61.7 ± 2.8 60.6± 3.7 66.5±1.3  60.7±2.7 64.2±1.8 62.6±3.0  61.9±3.5 61.0± 3.4 66.0±2.9  59.2±5.7 62.3±2.7 68.0±1.6 
n-3  0.6 ± 0.1 0.3± 0.1 0.3±0.1  0.6±0.2 0.3±0.1 0.4±0.1  0.6±0.2 0.3± 0.1 0.3±0.1  0.7±0.2 0.5±0.2 0.5±0.2 
n-6  61.1 ± 2.7 60.3± 3.6 66.1±1.2  60.0±2.5 63.9±1.8 62.2±2.9  61.3±3.5 60.7± 3.5 65.7±2.9  58.4±5.6 61.8±2.7 67.5±1.6 
 
Values given are mean ± SEM; all diet groups n = 6. 
FA = fatty acid; AD = high amylose/DAG; AT = high amylose/TAG; WD = waxy corn/DAG; WT = waxy corn/TAG; PL = phospholipid;                 
EC = esterified cholesterol; SFA = saturated fatty acids; MUFA = monounsaturated fatty acids; PUFA = polyunsaturated fatty acids. 
Superscript letters not in common in a row within a diet group indicate a significant difference between weeks by ANOVA, p < 0.05. 
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Plasma Phospholipid Fatty Acid Type Distribution.  Fatty acids detected in 
the plasma PL fraction were grouped as described previously and relative percentages 
were summed and averaged (Table 3).  One-way ANOVA identified an overall diet 
effect for n-3 FA and a diet effect at wk 8 for n-6 FA, but multiple comparisons 
demonstrated no significant differences in both cases.  An overall time effect was shown 
for SFA and n-3 FA.  Saturated FA decreased from wk 4 to wk 8, but relative 
percentages at wk 1 were similar to both subsequent measurements.  Multiple 
comparisons revealed that n-3 FA concentrations decreased from wk 1 to wk 4, then 
returned to baseline values at wk 8. 
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Cat Study 
 
 Animals and Diets.  Daily monitoring of food intake revealed no aversion to the 
test diets and all cats that completed the study maintained a healthy weight throughout 
the experimental period.  One of the cats assigned to diet H was found to have oral 
lesions early on during the feeding period consistent with calici virus and was removed 
from the study. 
 Plasma Cholesterol.  Total cholesterol concentrations showed no differences 
due to time, diet, or time × diet interactions (Appendix C, Figure C-1).  Both UC and EC 
exhibited main time effects, with UC concentrations decreased at d 28 relative to days 0 
and 14 (Appendix C, Figure C-2) and EC concentrations increased at d 28 relative to 
days 0 and 14 (Appendix C, Figure C-3).  No diet effects or diet × time interactions were 
seen for UC or EC. 
 LCAT Activity.  No diet, time, or diet × time interactions were seen in LCAT 
activity (Figure 3). 
 Plasma Esterified Cholesterol Fatty Acid Composition.  No differences in 
relative percentages of individual fatty acids in the plasma EC fraction were observed 
between diet groups at baseline (Table 4).  As expected, diet effects were widely seen 
within subsequent time points.  As early as d 14, 14:0, 16:0, 16:1n-7, 18:3n-3, 20:4n-6,  
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Figure 3 LCAT activities of cats fed diets enriched with high oleic (n = 9), 
menhaden fish (n = 10), or safflower (n = 10) oil.  Values are mean ± SEM. 
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Table 4 Cat study plasma esterified cholesterol fatty acid composition (relative %) 
FA  Diet H (n = 9) Diet M (n = 10) Diet S (n = 10) 
 Day 0 Day 14 Day 28 Day 0 Day 14 Day 28 Day 0 Day 14 Day 28 
14:0 0.19± 0.04 0.30± 0.051 0.20±0.021  0.12±0.04a 0.75±0.09b,2 0.50± 0.04c,2  TR 0.26±0.081 0.17±0.011 
14:1n-5 TR ND TR  ND TR ND  ND TR ND 
16:0 9.65± 0.50ab 10.12± 0.74a,1 7.69±0.24b,1  9.69±0.21a 16.02±1.28b,2 11.74± 0.35b,2  9.00±0.50a 10.09±0.65a,1 6.90±0.22b,1 
16:1n-7 1.05± 0.05a 0.82± 0.05ab,1 0.75±0.05b,1  0.87±0.06a 2.04±0.12b,2 1.82± 0.11b,2  0.88±0.07a 0.71±0.08ab,1 0.55±0.06b,1 
17:0 TR TR ND  TR TR TR  TR 0.11±0.05 ND 
18:0 1.21± 0.03 1.50± 0.16 1.16±0.091,2  1.33±0.07a 1.84±0.17b 1.46± 0.08ab,1 1.33±0.08ab 1.81±0.23a 1.09±0.09b,2 
18:1 iso ND 2.47± 1.22 0.32±0.30  ND 1.19±0.86 ND  ND ND ND 
18:1n-7 1.96± 0.07 3.59± 0.921,2 1.48±0.191,2  1.98±0.09a 3.17±0.41b,1 2.49± 0.07b,1  1.87±0.12ab 2.02±0.21a,2 1.42±0.16b,2 
18:1n-9 20.42± 0.82a 28.11± 1.20b,1 29.40±0.79b,1  19.85±0.70a 17.78±0.64b,2 18.07± 0.35ab,2 19.01±0.64a 12.77±0.59b,3 12.88±0.67b,2 
18:2n-6 56.72± 0.55a 48.02± 1.99b,1 53.40±0.91ab,1 55.12±0.91a 38.25±2.03b,2 41.27± 0.76b,2  55.99±1.03a 65.71±2.33ab,3 73.19±1.10b,3 
18:3n-3 0.41± 0.06a 0.22± 0.05b,1 0.32±0.02ab,1 0.45±0.02 0.48±0.062 0.48± 0.032  0.43±0.05a 0.21±0.13b,1 0.19±0.02b,3 
20:0 ND ND ND  ND 0.11±0.11 ND  ND 0.19±0.19 ND 
20:1n-9 ND ND ND  ND TR ND  ND 0.14±0.14 ND 
20:2n-6 ND ND ND  ND TR ND  ND 0.13±0.13 ND 
20:3n-3 ND ND ND  ND TR ND  ND 0.13±0.13 ND 
20:3n-6 0.18± 0.04 0.12± 0.04 0.23±0.031  0.30±0.02a 0.19±0.08b 0.20± 0.02b,1  0.25±0.06 0.16±0.14 0.10±0.022 
20:4n-6 5.87± 0.27a 3.25± 0.29b,1 3.95±0.30b,1  6.44±0.47 6.18±0.462 7.04± 0.222  7.81±0.83a 3.13±0.26b,1 2.77±0.25b,1 
20:5n-3 1.53± 0.19a 0.70± 0.15b,1 0.87±0.07b,1  1.61±0.17a 10.62±0.87b,2 13.98± 0.88b,2  1.89±0.24a 0.31±0.14b,1 0.49±0.03b,1 
22:0 ND ND ND  ND TR ND  ND 0.14±0.14 ND 
22:1n-9 ND ND ND  ND TR ND  ND 0.15±0.15 ND 
22:4n-6 ND ND ND  ND ND ND  ND ND ND 
22:5n-3 ND ND ND  ND ND ND  ND ND ND 
22:6n-3 ND ND ND  ND ND ND  ND ND ND 
24:0 ND ND ND  ND ND ND  ND ND ND 
24:1 ND ND ND  ND ND ND  ND ND ND 
UI 0.69± 0.56 0.70± 0.44 0.19±0.16 2.18±1.00 0.89±0.59 0.87± 0.75 1.38±0.89 1.80±0.84 0.24±0.13 
  
Values given are mean ± SEM.  
FA = fatty acid; ND = not detected; TR = trace (< 0.1%); 18:1 iso = 18:1 isomers other than 18:1n-7 and 18:1n-9; UI = unidentified. 
Superscript letters not in common in a row within a diet group indicate a significant difference between days by ANOVA, p < 0.05. 
Superscript numbers not in common in a row within a day indicate a significant difference between diets by ANOVA, p < 0.05. 
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and 20:5n-3 relative percentages were higher in diet group M than in the other two diet 
groups.  Other differences seen at this time point were relative percentages of 18:1n-7,  
which was higher in diet group M than diet group S with diet group H similar to both; 
18:1n-9, which was significantly higher in diet group H than diet group M, which was in 
turn greater than diet group S; and 18:2n-6, which was greatest in diet group S, followed 
by diet group H, then diet group M.     
By d 28, further differences between diet groups were seen.  In addition to the 
same patterns for 14:0, 16:0, 16:1n-7, 18:1n-7, 18:2n-6, 20:4n-6, and 20:5n-3 as 
observed for d 14, there were also differences between diet groups in relative 
percentages of 18:0 and 20:3n-6 as well as differences for 18:1n-9 and 18:3n-3 other 
than those observed on d 14.  Relative percentages of 18:1n-9 were higher for diet group 
H than the other two diet groups, and 18:3n-3 concentrations were different for all three 
diet groups, with diet group M being greatest, followed by diet group H, then S.  Diet 
group M exhibited higher 18:0 concentrations than diet group S with diet group H 
similar to both.  Lower 20:3n-6 concentrations were found in cats fed diet S than those 
fed diets M or H.   
 Widespread time effects within each diet group were also observed for the 
plasma EC fatty acid composition.  In cats fed diet H, relative percentages of 16:0, 
16:1n-7, 18:1 unidentified isomers, 18:1n-9, 18:2n-6, 18:3n-3, 20:4n-6, and 20:5n-3 
changed over time.  At d 14, relative percentages of 16:0 were elevated relative to d 28, 
although d 0 was similar to both values.  The concentration of 16:1n-7 increased 
gradually from d 0 to d 28 such that d 14 values were similar to both.  Although one-way 
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ANOVA identified a time effect for 18:1 unidentified isomers, multiple comparisons did 
not indicate significant differences between time points.  Relative percentages of 18:1n-9 
increased from d 0 to d 14 and remained elevated at d 28.  Both 18:2n-6 and 18:3n-3 
relative percentages increased from d 0 to d 14 but dropped at d 28 so that values were 
similar to both previous measurements.  Concentrations of 20:4n-6 and 20:5n-3 were 
both increased at days 14 and 28 compared to baseline.  Diet group M exhibited 
differences in the relative percentages of 14:0, 16:0, 16:1n-7, 18:0, 18:1n-9, 18:2n-6, 
20:3n-6, and 20:5n-3 over time.  Concentrations of 14:0 increased from baseline to d 14, 
then decreased at d 28 but remained higher than at d 0.  Relative percentages of 16:0, 
16:1n-7, 18:1n-7, and 20:5n-3 were elevated at d 14 compared to baseline and remained 
so at d 28.  At d 14, concentrations of 18:0 had increased from baseline values only to 
decrease at d 28 so that values were similar to both previous measurements.  Conversely, 
18:1n-9 relative percentages decreased from baseline to d 14, then increased such that 
values at d 28 were not different than previous measurements.  Both 18:2n-6 and 20:3n-6 
concentrations declined from d 0 to d 14 and remained so at d 28.  Cats fed diet S had 
altered levels of 16:0, 16:1n-7, 18:0, 18:1n-7, 18:1n-9, 18:2n-6, 18:3n-3, 20:3n-6, 20:4n-
6, and 20:5n-3 in plasma EC over time.  Relative percentages of 16:0 remained steady 
from baseline to d 14 and decreased at d 28.  Palmitic acid (16:1n-7) levels decreased 
gradually from d 0 to d 28 such that values at d 14 were similar to both.  Concentrations 
of 18:0 and 18:1n-7 were lower at d 28 than at d 14, although baseline values were 
similar to both subsequent measurements.  A decrease in relative percentages of 18:1n-9, 
18:3n-3, 20:4n-6, and 20:5n-3 occurred from baseline to d 14 and remained at d 28.  
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Linoleic acid (18:2n-6) concentrations were elevated at d 28 compared to d 0 with d 14 
values similar to both.  Although one-way ANOVA identified a difference in 20:3n-6 
relative percentages over time, multiple comparisons indicated no significant differences. 
 Plasma Esterified Cholesterol Fatty Acid Type Distribution.  Fatty acids 
detected in the plasma EC fraction were grouped as described previously and 
summarized in Table 5.  As with the plasma EC fatty acid profiles, no significant 
differences between diets were found at baseline but many differences were found 
between diets at subsequent time points.  At d 14, n-3 and saturated FA relative 
percentages were higher in diet group M than in the other two diet groups.  
Monounsaturated fatty acid concentrations were different for each diet group, with H 
having the highest, followed by M, then S.  Both n-6 and polyunsaturated FA levels 
were elevated in diet group S relative to the other two diet groups.  Day 28 FA type 
distributions had identical differences between groups as d 14. 
  Time effects on fatty acid type distribution within diet groups were also 
prevalent.  Relative percentages of SFA, MUFA, PUFA, and n-3 and n-6 FA varied with 
time in cats fed diet H.  Greater SFA concentrations were seen at d 14 than at d 28, 
although values at both time points were similar to baseline values.  Monounsaturated 
FA levels were increased relative to baseline at d 14 and remained so at d 28.  A 
decrease in polyunsaturated, n-3, and n-6 FA concentrations was observed at d 14 that 
was sustained at d 28.  Diet group M displayed time effects for SFA, PUFA, and n-3 and 
n-6 fatty acid relative percentages.  Saturated and n-3 FA levels were elevated compared 
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Table 5 Cat study plasma esterified cholesterol fatty acid type distribution (relative %) 
FA 
Type  
Diet H  
(n = 9) 
Diet M  
(n = 10) 
Diet S  
(n = 10) 
  Day 0 Day 14 Day 28 Day 0 Day 14 Day 28 Day 0 Day 14 Day 28 
SFA  11.12 ± 0.54ab 12.00± 0.97a,1 9.05±0.32b,1 11.20±0.21a 18.86±1.56b,2 13.79 ± 0.35b,2 10.48±0.59a 12.61±1.09a,1 8.16±0.29b,1
MUFA 23.48 ± 0.91a 34.99± 1.43b,1 31.98±0.90b,1 22.70±0.73 24.38±1.032 22.38 ± 0.362 21.76±0.80a 15.81±0.66b,3 14.85±0.88b,3
PUFA  64.71 ± 0.72a 52.31± 2.32b,1 58.77±1.14b,1 63.91±1.15a 55.87±2.91b,1 62.96 ± 0.72ab,1 66.37±1.46a 69.78±2.03a,2 76.75±1.22b,2
n-3  1.94 ± 0.23a 0.92± 0.18b,1 1.19±0.09b,1 2.06±0.19a 11.17±0.89b,2 14.45 ± 0.90b,2 2.32±0.28a 0.65±0.30b,1 0.68±0.05b,1
n-6  62.77 ± 0.60a 51.39± 2.33b,1 57.58±1.12b,1 61.85±1.07a 44.70±2.42b,1 48.51 ± 0.79b,2 64.04±1.42a 69.13±2.25a,2 76.06±1.21b,3
 
Values given are mean ± SEM. 
FA = fatty acid; SFA = saturated fatty acids; MUFA = monounsaturated fatty acids; PUFA = polyunsaturated fatty acids. 
Superscript letters not in common in a row within a diet group indicate a significant difference between weeks by ANOVA, p < 0.05. 
Superscript numbers not in common in a row within a day indicate a significant difference between diets by ANOVA, p < 0.05. 
 
 
36 
 
to baseline values at both d 14 and d 28.  Polyunsaturated fatty acids increased from 
baseline to d 14, then decreased at d 28 so that values were similar to both previous 
measurements.  Concentrations of n-6 FA were decreased at days 14 and 28 relative to 
baseline values.  Cats fed diet S exhibited differences due to time for saturated, 
monounsaturated, polyunsaturated, n-3, and n-6 fatty acids.  Levels of SFA were stable 
from baseline to d 14, then dropped at d 28.  Monounsaturated and n-3 FA 
concentrations decreased from baseline to d 14 and remained so at d 28.  Relative 
percentages of polyunsaturated and n-6 fatty acids showed no change from d 0 to d 14, 
then increased at d 28. 
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CHAPTER IV 
DISCUSSION 
 
 Because the dogs were offered the estimated number of calories required to 
maintain their starting obese body weights, the voluntary diet restriction of the dogs 
resulted in consistent weight loss in all diet groups.  Therefore, in the absence of 
differences due to diet, differences due to time could be attributed to the effects of the 
weight loss that occurred.  Also, due to the decreased digestibility of the LGI starch diets, 
greater percentage body weight loss occurred in dogs that received those diets than in 
dogs fed the HGI starch diets.   
Significant differences were identified in plasma cholesterol concentrations.  
Concentrations of both TC and EC were lower in the LGI starch group than in the HGI 
starch group.  Typically, plasma cholesterol concentrations are associated with dietary 
fat intake, so a starch effect on TC and EC seems surprising.  An overall starch effect 
indicates that differences were present even at wk 1, before the experimental diets were 
fed.  The presence of differences between starch groups at baseline makes differences at 
subsequent time points difficult to interpret.  Additionally, because certain samples were 
excluded from the analysis as described previously, the sample size of some groups was 
reduced which may have contributed to the considerable variability of the remaining 
results.  With these confounding factors in mind, although a statistical difference due to 
starch type was observed for the TC and EC data, the physiological significance of these 
findings are uncertain. 
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On the other hand, UC concentrations exhibited significant differences due to 
time: an initial increase from wk 1 to wk 4, then a non-significant decrease toward 
baseline from wk 4 to wk 8.  As stated earlier, a time effect in the absence of a diet effect 
could indicate a physiological effect of weight loss.  In this case, weight loss initially 
occurred in conjunction with a rise in plasma UC concentration, then it seems that 
adaptation moderated the change in UC so that the subsequent measurement was similar 
to both baseline and wk 4 values.  Interestingly, a similar pattern of change was observed 
in LCAT activity, which also exhibited significant differences due to time.  After a 
significant increase from wk 1 to wk 4, LCAT activity decreased at wk 8, although not 
significantly.  Again, this time effect might be due to the weight loss that occurred 
during this interval; however, these changes are more likely due to substrate availability.   
As concentrations of UC (the substrate for LCAT) increased, so did the enzyme’s 
activity.  This result is not surprising considering that enzyme activity is often regulated 
by substrate availability and that this mechanism is recognized as the major regulator of 
LCAT activity (14).   
The experimental oils were designed to have similar fatty acid contents and as 
expected, fatty acid profiles of plasma EC and PL fractions demonstrated sparse 
differences due to oil, starch, diet, or time.  The few statistical differences seen in the 
dog EC and PL fatty acid profiles consist of small numerical differences between groups.  
The majority of the statistical differences identified resulted from differences between 
groups of < 0.5 relative percent, and the largest difference identified between groups was 
only ~2.7 relative percent.  Many of the statistical differences occurred in FA present as 
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< 1 relative percent in the fatty acid profiles.  Such small amounts are approaching the 
detection limit of the methods used in this study, and the slight differences identified 
statistically may not reflect true differences due to the sensitivity of the methods 
employed and interassay variation.  Regardless of statistical significance, such small 
differences in fatty acid profiles likely have little physiological significance.  As such, 
the isomeric differences of TAG and DAG oil do not translate into differences in FA 
composition of the plasma PL or EC fractions. 
Linoleic acid constituted the major fatty acid in the plasma EC fraction in all diet 
groups, with concentrations much higher than those found in plasma PL.  This is 
consistent with reports by others that canine LCAT exhibits substrate specificity for LA 
(23).  Interestingly, this same phenomenon was also observed with 24:1.  Concentrations 
of 24:1 detected in plasma EC were roughly 5 times those found in plasma PL on 
average, indicating that canine LCAT also shows specificity for this FA, which was 
present in the diet at 0.57 relative percent, on average.  A previous unpublished study in 
this lab did not find substantial amounts of 24:1 in canine plasma EC; however, the 
experimental diets in that study did not contain detectable amounts of 24:1 (27).  
As with the fatty acid profiles of the dog plasma EC and PL fractions, the fatty 
acid type distributions of those fractions exhibited few significant differences because of 
the similar fatty acid profiles of the experimental oils and diets.  The differences 
observed between groups for n-3 FA concentration in both EC and PL FA profiles were 
all <1 relative percent, and for reasons stated previously are likely of little physiological 
significance.  The other differences seen in the FA type distributions were all modest 
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time effects, which could either be attributed to interassay variation or differences 
between the acclimation diet and the experimental diets.  In the plasma EC fraction, SFA 
decreased by about 3 relative percent and n-6 FA concentrations increased by about 5 
relative percent from wk 1 to wk 8.  This alteration may reflect the slightly higher SFA 
and lower n-6 FA content of the acclimation diet relative to the experimental diets, on 
average. 
An unexpected finding in the cat study was the significant decrease in plasma UC 
and increase in plasma EC concentrations at d 28, especially in the absence of any 
change in plasma LCAT activity or TC concentration.  This redistribution of the 
cholesterol fractions could be related to a decrease in dietary fat intake, which occurred 
when the cats were switched from the pre-experimental diet, which was 24.3% fat as is, 
to the experimental diets, which were on average 16.8% fat as is.  Because most 
commercial pet foods contain little cholesterol, most of the plasma cholesterol in these 
cats was synthesized endogenously from fatty acids provided by the diet, which not only 
serve as substrate but also as stimulus for cholesterol production.  A decrease in the 
amount of fat available for use in and stimulus of de novo cholesterol synthesis could 
lead to decreased endogenous cholesterol (as UC) production.  Plasma TC 
concentrations depend not only on its absorption from the diet and endogenous synthesis, 
but also on its rate of uptake and release by tissues.  A decrease in cholesterol synthesis 
could take place in the absence of a decrease in plasma TC concentrations if it occurs 
concomitantly with a decrease in uptake or an increase in release of cholesterol by 
tissues.  Indeed, stable LCAT activity could indicate that the increase in circulating EC 
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is due not to an increase in UC esterification, but possibly to decreased uptake of EC by 
tissues.  Thus, a decrease in UC synthesis may have occurred in equal proportion to a 
decrease in EC uptake by tissues such that TC concentrations remained constant.   
Changes in plasma LCAT activity were not expected in the cats.  The primary 
objective of measuring LCAT activity in this species was simply to expand current 
knowledge of this enzyme in a seldom studied species.  No statistical differences were 
identified between diet groups or time points, and averaging all the data to obtain an 
LCAT activity in adolescent (7- to 10-month-old) cats yielded a value of 92.4 ± 4.5 nmol 
of UC esterified/ml of plasma/hr (mean ± SEM).  This is quite a bit lower than the value 
reported for adolescent (8-month-old) cats by Butterwick et al (239 ± 44 nmol of UC 
esterified/ml of plasma/hr [mean ± SEM]) (21).  This disparity has several possible 
explanations, mainly differences in methodology used to measure LCAT.  Butterwick et 
al employed an artificial proteoliposome substrate method (21), whereas the present 
study utilized a radiochemical method which relies on endogenous substrate.  The 
former method optimizes the substrate for LCAT, potentially yielding higher activities, 
while the latter method is more reflective of actual conditions within the animal.  
Another factor that could have produced differences in LCAT activity between the two 
studies is the TC concentration.  Butterwick et al reported a cholesterol concentration of 
6.03 ± 1.22  mmol/l (mean ± SD) for adolescent cats (21), whereas the present study 
determined a concentration of 3.03 ± .09 mmol/l (mean ± SEM) for total cholesterol.  It 
is possible that the elevated TC concentrations present in the former study compared to 
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the latter could have lead to increased circulating LCAT due to increased substrate, 
although the former study did not determine the UC concentration.   
Extensive differences between diets and over time were seen in the plasma EC 
FA profiles due to the different FA profiles of the oils fed.  Interestingly, linoleic acid 
(LA, 18:2n-6) constituted the major FA in plasma EC in all diet groups after 28 days of 
feeding, even though it was present as only 13.5 and 11.4 relative percent of the fat in 
diets H and M, respectively.  This is consistent with a report by Liu et al that LA is the 
major FA in feline plasma EC, although diet was not reported in that study (23).  
Considering the amounts of LA supplied by the diets in the present study, the presence 
of such high concentrations of LA in the plasma EC FA profile indicates a strong 
specificity of feline LCAT for LA.   
Another FA present in greater percentages in the plasma EC fraction of all diet 
groups at d 28 than in the diet was AA.  Arachidonic acid was present in almost 3 
relative percent of plasma EC after 28 days of feeding diet S, which contained no 
detectable amounts of AA.  This represents a decrease from baseline values, which can 
be attributed to lower content of AA in diet S compared to the pre-experimental diet.  
Nonetheless, AA was only present as <1 relative percent in the pre-experimental diet FA 
profile, and baseline values of AA in the plasma EC FA profiles of the cats averaged 
6.71 ± 0.36 relative percent (mean ± SEM) overall.  The presence of AA in plasma EC at 
these levels considering the amount supplied by the diet indicates a notable affinity of 
feline LCAT for AA and poses an interesting question regarding the origin of the AA 
given the limited Δ-6 desaturase activity in feline species.  Some studies have reported 
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decreased AA content of plasma lipids in animals fed diets supplemented with fish oil 
(FO) (28, 29).  This response was not seen in the plasma EC fraction in the present study.  
At days 14 and 28, cats fed diet M exhibited greater AA content in plasma EC than cats 
fed diets H or S.  However, in the previously mentioned studies, the diets fed (FO-
supplemented and control or alternate experimental diet) provided approximately equal 
amounts of AA as a percentage of total FA.  In the present study, diet M provided more 
AA than either diet H or S.  This pattern of greater plasma lipid AA content in animals 
fed a FO-supplemented diet containing more AA than the alternate experimental diets is 
consistent with other studies.  Horses fed a FO-supplemented diet vs. a corn oil (CO)-
supplemented diet exhibited increased concentrations of AA in plasma lipids, reflecting 
the greater concentration of AA in the FO compared to the CO diet (30).  Thus, the 
effect of FO feeding on AA content of plasma lipids seems to be related to the AA 
content of the complete diet. 
Cats fed diet M were consuming roughly 5% of their FA as EPA, yet the 
concentration of this FA in their plasma EC was almost 14% of the total FA after 28 
days of feeding.  This was an 8-fold increase from baseline values, when their diet 
provided approximately 1% of FA as EPA.  Even in diet groups H and S, which 
provided either very little or no EPA, this FA could be detected in their plasma EC FA 
profile at d 28, albeit at <1 relative percent.  These findings suggest that, in addition to 
LA and AA, feline LCAT also shows a favorable affinity for EPA.   
Notably absent in the plasma EC FA profile was DHA.  As with EPA, DHA was 
present in diet M as roughly 5% of total FA.  However, unlike EPA, DHA was not 
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detected in plasma EC even after 28 days of feeding.  This finding is consistent with 
results published by Platinga and Beynen reporting that cats fed a diet enriched with 
DHA had no detectable DHA in plasma EC (22) and contradicts the findings of Liu et al, 
who reported incorporation of DHA into feline plasma EC, although only at <1 weight 
percent (23).  Fatty acid analysis methodology varied among the studies, present 
included, to which disparate results might be attributable.  Further research into the 
incorporation of DHA into feline plasma is necessary to elucidate this aspect of fatty 
acid metabolism.  Docosapentanoic acid (DPA, 22:5n-3) was also present in diet M but 
not detectable in plasma EC even at d 28.  One possible explanation is that DPA was 
present only at approximately 1% of total fatty acids and this was not enough to support 
incorporation into plasma EC, but other FA comprising 1% or less of total FA, such as 
α-linolenic acid (ALA, 18:3n-3) and AA, were detectable in plasma EC.  Another 
possibility is that feline LCAT has no measurable affinity for DPA.  To our knowledge, 
this is the first study to mention DPA in relation to cat plasma EC.  This is another area 
which can benefit from further research. 
One of the more surprising results obtained in this study was that plasma EC FA 
profiles showed statistically significant changes in some FA as early as d 14.  Other FA 
concentrations changed gradually from baseline to d 28.  There was some concern at the 
planning stages of this project as to whether 28 days would be enough time to effect 
changes in feline FA metabolism.  Our results indicate that early changes can be detected 
in as little as 14 days with further effects being apparent at 28 days.  A longer study with 
more sampling periods would be necessary to establish a timeline for achieving a 
45 
 
metabolic steady state, but our data demonstrate that a 28-day study is adequate to 
measure changes in FA metabolism. 
The plasma EC fatty acid type distributions were strongly impacted by the fatty 
acid type distributions of the diets.  Each of the changes seen over time reflect 
differences between the fatty acid type distributions of the pre-experimental diet and the 
experimental diets.  Notably, PUFAs constitute the major fatty acid type in the plasma 
EC in each diet group at all sampling times, even though they are not the major fatty 
acid type in the pre-experimental diet or diets H or M.  Similarly, n-6 FA greatly exceed 
n-3 FA in the plasma EC.  Both of these phenomena result from the predominance of LA 
in the plasma EC.  In cats fed diet M, n-3 FA increased markedly due to the 
incorporation of EPA into plasma EC.  Our data clearly show that although diet 
influences feline plasma EC fatty acid type distributions, the substrate specificity of 
feline LCAT for specific PUFAs is the major determinant of the plasma EC fatty acid 
type distribution. 
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CHAPTER V 
SUMMARY 
 
 These investigations into diet effects on LCAT activity and substrate specificity 
have contributed to the current knowledge of cholesterol metabolism in two companion 
animal species.  An increase in LCAT activity and plasma UC concentration was 
observed in conjunction with weight loss in dogs.  No diet effects were seen on these 
two parameters, indicating that the changes in LCAT activity and UC concentration were 
indeed due to weight reduction as all diet groups experienced weight loss.  Oil type 
(TAG vs. DAG) did not affect the plasma EC or PL fatty acid composition or fatty acid 
type distribution.  This is likely due to the similar fatty acid composition of the 
experimental oils and indicates that positional isomers in oil do not affect resultant FA 
profiles.   
 No diet or time effects were seen on LCAT activities in cats fed diets differing in 
fatty acid composition.  Thus, the values for all cats at all time points were averaged to 
obtain a basal LCAT activity for adolescent cats of 92.4 ± 4.5 nmol of UC esterified/ml 
of plasma/hr (mean ± SEM).  This is quite a bit lower than the value for LCAT activity 
in adolescent cats reported by others, probably due to differences in methodology.   
The substrate specificity of feline LCAT for LA was demonstrated as this was 
the major FA in the plasma EC fraction in all cats even though LA was the major FA in 
only one of the experimental diets.  In cats fed diet M, greater concentrations of EPA 
were found in the plasma EC fraction than were supplied by the diet, indicating an 
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affinity of feline LCAT for this fatty acid.  Even though similar amounts of EPA and 
DHA were supplied by diet M and significant amounts of EPA were detected in the 
plasma EC fraction, no DHA was identified in this fraction, indicating very little or no 
affinity of feline LCAT for DHA.  Diet M supplied DPA as well, but this FA was also 
absent in the plasma EC fraction, suggesting little or no affinity of feline LCAT for DPA. 
Notably, some changes in feline plasma EC fatty acid composition were 
statistically significant after only 14 days of feeding the experimental diets.  This 
indicates rapid modification of feline FA metabolism by dietary fatty acid composition. 
By d 28, further significant differences due to time were seen, indicating that while 
initial differences can be seen in as little as 14 days, a longer study period is necessary to 
establish a metabolic steady state.  Whether 28 days is enough time to accomplish this 
cannot be determined by the present study, but we did demonstrate that it is a long 
enough study period to observe alterations in feline FA metabolism. 
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APPENDIX A 
 
Table A-1 Fatty acid composition of TAG 
and DAG oils in dog study (relative %) 
 Fatty Acid TAG DAG 
14:0 TR TR 
16:0 4.94 2.76 
16:1n-7 0.14 0.11 
17:0 TR TR 
18:0 1.89 1.33 
18:1 32.09 37.34 
18:2n-6 50.31 47.60 
18:3n-3 7.49 6.57 
20:0 0.36 0.33 
20:1 0.63 0.70 
20:2n-6 TR TR 
20:3n-6 ND ND 
20:4n-6 ND ND 
22:0 0.26 0.29 
22:1 0.14 TR 
24:0/22:6n-3 TR 0.10 
24:1 0.10 0.10 
Unidentified 1.34 2.53 
 
Values are averages of two representative samples.    
ND = not detected; TR = trace (< 0.1%).
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Table A-2 Ingredients of experimental diets in dog study 
 Diet 
Component WD WT AD AT 
 (g/kg) 
Chicken byproduct meal 430 430 430 430 
High amylose corn starch - - 430 430 
Waxy corn starch 430 430 - - 
Vitamin/mineral pre-mixa 5 5 5 5 
DAG 135 - 135 - 
TAG - 135 - 135 
Water 2595 2595 1730 1730 
 
a Contains: copper 4000 mg/kg; iodine 560 mg/kg; iron 2.4%; manganese 2000 mg/kg; 
selenium 120 mg/kg; zinc 4.32%; vitamin A 218 mg/kg; vitamin D3 2.95 mg/kg; vitamin E 
5455 mg/kg; vitamin B12 1.82 mg/kg; riboflavin 272.7 mg/kg; d-pantothenic acid 1364 
mg/kg; thiamine 75 mg/kg; niacin 3182 mg/kg; vitamin B6 90.9 mg/kg; folic acid 143.6 
mg/kg; choline chloride 41.2 g/kg; choline 35.8 g/kg; d-biotin 4.5 mg/kg 
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Table A-3 Fatty acid composition of experimental dietsa in 
dog study (relative %) 
 Diet
Fatty Acid AD AT WD WT 
14:0 0.23 0.19 0.25 0.38 
14:1n-5 ND ND TR ND 
16:0 11.55 12.54 10.30 16.40 
16:1n-7 2.15 1.89 2.26 3.52 
17:0 TR 0.10 TR 0.12 
17:1 0.11 ND 0.11 ND 
18:0 4.11 5.36 3.89 5.66 
18:1n-7 3.89 10.04 2.89 3.31 
18:1n-9 39.67 31.19 38.74 36.57 
18:2n-6 30.10 29.86 32.91 27.08 
18:3n-3 2.76 3.28 3.33 2.93 
20:0 0.41 0.65 0.72 0.42 
20:1n-9 0.93 0.94 0.65 0.58 
20:2n-6 ND 0.17 ND ND 
20:3n-3 ND ND ND ND 
20:3n-6 ND ND ND ND 
20:4n-6 0.37 0.28 0.43 0.37 
20:5n-3 ND ND ND ND 
22:0 TR 0.60 0.39 0.41 
22:1n-9 ND 0.19 TR 0.13 
22:4n-6 TR ND TR ND 
22:5n-3 ND ND ND ND 
22:6n-3 0.36 0.78 0.42 0.68 
24:0 ND ND ND ND 
24:1 0.60 0.55 0.49 0.63 
Unidentified 2.53 1.38 1.92 1.20 
SFA 16.46 19.44 15.64 23.39 
MUFA 47.35 44.80 45.27 44.74 
PUFA 33.67 34.37 37.18 31.05 
n-3 3.12 4.06 3.75 3.60 
n-6 30.55 30.31 33.43 27.45 
 
a All diets 19.7% fat (as fed) and 4228 kcal/kg as estimated by calculation 
from nutrient composition using modified Atwater factors. 
Values are averages of two representative samples. 
 ND = not detected; TR = trace (< 0.1%); AD = high amylose/DAG;     
AT = high amylose/TAG; WD = waxy corn/DAG; WT = waxy 
corn/TAG; SFA = saturated fatty acids; MUFA = monounsaturated fatty 
acids; PUFA = polyunsaturated fatty acids.  
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Table A-4 Fatty acid composition of 
acclimation dieta in dog study   
 Fatty Acid Relative % 
 14:0 0.30
 14:1n-5 ND
 16:0 13.77
 16:1n-7 2.37
 17:0 ND
 17:1 ND
 18:0 5.11
 18:1n-7 3.17
 18:1n-9 38.15
 18:2n-6 28.31
 18:3n-3 5.45
 20:0 0.56
 20:1n-9 0.62
 20:2n-6 ND
 20:3n-3 ND
 20:3n-6 ND
 20:4n-6 0.41
 20:5n-3 ND
 22:0 ND
 22:1n-9 ND
 22:4n-6 ND
 22:5n-3 0.28
 22:6n-3 0.41
 24:0 0.33
 24:1 0.26
 Unidentified 0.23
 SFA 20.07
 MUFA 44.57
 PUFA 35.13
 n-3 6.14
 n-6 28.99
 
a 19.7% fat (as fed) and 4228 kcal/kg as 
estimated by calculation from nutrient 
composition using modified Atwater factors. 
Values are averages of two representative 
samples.  
ND = not detected; SFA = saturated fatty 
acids; MUFA = monounsaturated fatty acids; 
PUFA = polyunsaturated fatty acids. 
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Figure A-1 Total cholesterol concentrations of dogs fed diets differing in starch 
type (high amylose [A] or waxy corn [W]) and oil type (diacylglycerol [D] or 
triacylglycerol [T]).  Sample sizes varied, see text for description.  Values are mean 
± SEM.  
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Figure A-2 Unesterified cholesterol of dogs fed diets differing in starch type (high 
amylose [A] or waxy corn [W]) and oil type (diacylglycerol [D] or triacylglycerol 
[T]).  Sample sizes varied, see text for description.  Values are mean ± SEM.  
Letters not in common indicate a significant difference between weeks by repeated 
measures ANOVA, p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-3 Esterified cholesterol concentrations of dogs fed diets differing in 
starch type (high amylose [A] or waxy corn [W]) and oil type (diacylglycerol [D] or 
triacylglycerol [T]).  Sample sizes varied, see text for description.  Values are mean 
± SEM.  
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APPENDIX B 
 
Calculation of LCAT activity: 
 
LCAT activity (nmol of UC esterified/ml·hr) = (A – B) × (median of all Ca ÷ C) × D 
 
A = Sample EC ÷ (Sample EC + Sample UC)b 
B = Blank EC ÷ (Blank EC + Blank UC)b 
C = Control EC ÷ (Control EC + Control UC)b 
D = Plasma UC (mg/dl)c × (1 g / 1000 mg) × (1 mol / 386.66 g of UC) ×                      
(109 nmol / 1 mol) × (1 dl / 100 ml) × 0.2 ml × 5  × 2 
 
 
 
a Median value of 17 control plasma samples 
b As determined by LCAT activity assay 
c As determined by plasma cholesterol analysis 
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APPENDIX C 
 
Table C-1 Fatty acid composition of pre-
experimental period dieta in cat study 
  Fatty Acid Relative % 
 14:0 1.46
 14:1n-5 TR
 16:0 21.86
 16:1n-7 3.43
 17:0 0.30
 18:0 9.80
 18:1n-7 3.15
 18:1n-9 35.88
 18:2n-6 17.25
 18:3n-3 1.87
 20:0 0.29
 20:1n-9 0.73
 20:2n-6 0.48
 20:3n-3 TR
 20:3n-6 0.15
 20:4n-6 0.62
 20:5n-3 1.03
 22:0 ND
 22:1n-9 ND
 22:5n-3 0.17
 22:6n-3 ND
 24:0 0.68
 24:1 ND
 Unidentified 0.71
 SFA 34.39
 MUFA 43.24
 PUFA 21.65
 n-3 3.15
 n-6 18.50
 
a Hill’s Science Diet® Kitten Original; 24.8% fat 
and 4208 kcal/kg as reported by manufacturer.  
Values are averages of two representative samples. 
ND = not detected; TR = trace (< 0.1%);            
SFA = saturated fatty acids;                              
MUFA = monounsaturated fatty acids;             
PUFA = polyunsaturated fatty acids. 
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Table C-2 Fatty acid composition and diet characteristics of experimental kibble, 
oils, and complete diets in cat study (relative %) 
  Oila Diet (kibble + oil) 
Fatty Acid  Kibblea H M S  Ha  Mb Sa 
14:0 1.55 TR 7.80 TR 1.38 4.19 1.45
14:1n-5 0.24 ND ND ND 0.23 0.28 0.23
16:0 17.05 3.36 15.88 5.98 14.35 19.84 15.39
16:1n-7 1.66 TR 11.36 TR 1.38 5.64 1.36
17:0 ND ND ND ND 0.57 0.83 0.51
18:0 9.43 3.23 2.80 2.35 9.26 10.14 8.50
18:1n-7 3.12 1.26 3.31 0.80 3.06 4.34 3.16
18:1n-9 43.98 82.37 7.02 13.52 53.98 23.57 24.59
18:2n-6 20.87 7.67 1.55 74.78 13.47 11.36 43.52
18:3n-3 1.17 0.22 1.44 0.28 0.66 1.09 0.69
20:0 ND 0.29 0.16 0.46 0.34 0.30 0.37
20:1n-9 ND 0.24 1.42 0.17 0.29 0.78 0.23
20:2n-6 ND ND 0.26 ND ND ND ND
20:3n-3 ND ND 0.25 ND ND ND ND
20:3n-6 ND ND 1.05 ND ND 0.14 ND
20:4n-6 ND ND 0.24 ND 0.19 0.57 ND
20:5n-3 ND ND 14.09 ND 0.12 5.24 ND
22:0 ND 0.68 ND 0.19 ND 0.36 ND
22:1n-9 ND ND TR ND ND ND ND
22:4n-6 ND ND 0.19 ND ND ND ND
22:5n-3 ND 0.20 2.56 ND ND 1.02 ND
22:6n-3 ND ND 12.58 ND ND 5.13 ND
24:0 ND 0.18 ND TR 0.17 ND ND
24:1 ND ND 0.29 0.11 ND ND ND
Unidentified 0.92 0.30 15.74 1.36 0.55 5.17 0.00
SFA 28.04 7.78 26.64 9.14 26.08 35.67 26.23
MUFA 49.00 83.95 23.49 14.69 58.93 34.61 29.57
PUFA 22.04 8.10 37.75 75.07 14.44 24.55 44.21
n-3 1.17 0.42 34.45 0.28 0.78 12.48 0.69
n-6 20.87 7.67 3.30 74.78 13.66 12.07 43.52
% fat (as fed)c 11.6 - - - 16.6 16.1 17.7
kcal/kgd 3442 - - - 3816 3816 3816 
 
a Values are averages of two representative samples. 
b Values from one representative sample; according to the manufacturer’s specifications, contained 
significant amounts of fatty acids not present in our standard mixture, such as 3.53% of 18:4n-3. 
c Determined gravimetrically.  
d Estimated by calculation from nutrient composition using modified Atwater factors. 
ND = not detected; TR = trace (< 0.1%); SFA = saturated fatty acids; MUFA = monounsaturated fatty 
acids; PUFA = polyunsaturated fatty acids. 
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Figure C-1 Total cholesterol of cats fed diets enriched with high oleic (n = 9), 
menhaden fish (n = 10), or safflower (n = 10) oil.  Values are mean ± SEM. 
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Figure C-2 Unesterified cholesterol of cats fed diets enriched with high oleic (n = 9), 
menhaden fish (n = 10), or safflower (n = 10) oil.  Values are mean ± SEM.  Letters 
not in common indicate a significant difference between weeks by repeated measures 
ANOVA on transformed data, p < 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C-3 Esterified cholesterol of cats fed diets enriched with high oleic (n = 9), 
menhaden fish (n = 10), or safflower (n = 10) oil.  Values are mean ± SEM.  Letters 
not in common indicate a significant difference between weeks by repeated measures 
ANOVA on transformed data, p < 0.05. 
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